Myotonia
Showing 1 - 25 of 51
Non-Dystrophic Myotonia Trial in Nice (Questionnaire for Non-dystrophic myotonias)
Not yet recruiting
- Non-Dystrophic Myotonia
- Questionnaire for Non-dystrophic myotonias
-
Nice, Alpes Maritimes, FranceNice University Hospital
Nov 13, 2023
Myotonic Dystrophy 1 Trial in Palo Alto
Active, not recruiting
- Myotonic Dystrophy 1
-
Palo Alto, CaliforniaStanford Universtiy
Oct 12, 2023
Non-Dystrophic Myotonia Trial in Copenhagen (Lamotrigine, Namuscla)
Recruiting
- Non-Dystrophic Myotonia
-
Copenhagen, DenmarkCopenhagen Neuromuscular Center, department of Neurology, Rigsho
Dec 5, 2022
Myotonic Dystrophy, Congenital Myotonic Dystrophy, Myotonic Dystrophy 1 Trial in Oakland (Patient-entered data)
Recruiting
- Myotonic Dystrophy
- +15 more
- Patient-entered data
-
Oakland, CaliforniaMyotonic Dystrophy Foundation
Oct 31, 2022
Using MRI in Non-dystrophic Myotonia to Access Muscle
Recruiting
- Paramyotonia Congenita
- Nondystrophic Myotonia
- MRI
-
Copenhagen, DenmarkNeuromuscular Center Rigshospitalet
Sep 14, 2021
Hypertrofic Muscles in Patients With Non-Dystrophic Myotonia
Recruiting
- Non-Dystrophic Myotonia
- Myotonia Congenita
-
Copenhagen, DenmarkRigshospitalet
Mar 16, 2021
Non-Dystrophic Myotonia Trial in London (Mexiletine, Lamotrigine 25Mg Oral Tablet, Extended Release)
Recruiting
- Non-Dystrophic Myotonia
- Mexiletine
- Lamotrigine 25Mg Oral Tablet, Extended Release
-
London, United KingdomUniversity College London Hospital
Aug 23, 2021
Myotonic Dystrophy 1 Trial in Jette (Low frequency repetitive stimulation)
Completed
- Myotonic Dystrophy 1
- Low frequency repetitive stimulation
-
Jette, Brussels Hoofdstedelijk Gewest, BelgiumUZ Brussel
Dec 21, 2022
Myotonic Dystrophy Type 1 (DM1) Trial in Vikersund (Tyromotion Amadeo and Armeo Senso)
Recruiting
- Myotonic Dystrophy Type 1 (DM1)
- Tyromotion Amadeo and Armeo Senso
-
Vikersund, Viken, NorwayVikersund Rehabilitation Center
Sep 26, 2022
Clinical Outcome Measures in Myotonic Dystrophy Type 2
Completed
- Myotonic Dystrophy Type 2
- DM1-ActivC
- +18 more
-
Munich, Bavaria, GermanyFriedrich-Baur-Institute, Dep. of Neurology Klinikum der Univers
Feb 19, 2020
Myotonia Congenita, Paramyotonia Congenita, Myotonic Dystrophy 1 Trial in Columbus (Ranolazine)
Completed
- Myotonia Congenita
- +2 more
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Mar 1, 2019
Intensive Care Unit and in Primary Myopathies
Completed
- Sepsis
- Primary Myopathies
-
Basel, SwitzerlandUniversity of Basel Hospital
Nov 25, 2021
PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)
Completed
- Myotonic Dystrophy Type 1
-
Newcastle Upon Tyne, Tyne And Wear, United Kingdom
- +1 more
Apr 12, 2021
Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib, Placebo)
Recruiting
- Congenital Myotonic Dystrophy
- Tideglusib
- Placebo
-
Little Rock, Arkansas
- +14 more
Aug 11, 2022
Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)
Terminated
- Myotonic Dystrophy Type-1
- Myotonic Dystrophy Type-2
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 2, 2021
Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib)
Enrolling by invitation
- Congenital Myotonic Dystrophy
-
Little Rock, Arkansas
- +10 more
Nov 15, 2021
Stellate Ganglion, Parkinson Disease Trial in Guangzhou (Treatment (Stellate ganglion block;Oral standard anti-Parkinson's
Recruiting
- Stellate Ganglion
- Parkinson Disease
- Treatment (Stellate ganglion block;Oral standard anti-Parkinson's drugs)
- Treatment (Oral standard anti-Parkinson's drugs)
-
Guangzhou, Guangdong, ChinaZhujiang Hospiatal
Oct 26, 2023
Myotonic Dystrophy Type 1 and Type 2 Trial (Mexiletine 167 mg, Placebo)
Not yet recruiting
- Myotonic Dystrophy Type 1 and Type 2
- Mexiletine 167 mg
- Placebo
- (no location specified)
Jan 21, 2021
DM1 Patients in China
Enrolling by invitation
- Myotonic Dystrophy 1
- Brain MRI scan
-
Shanghai, ChinaHuashan Hospital
Oct 20, 2023
's Study of a Smartphone Application for Periodic Paralysis
Recruiting
- Periodic Paralyses
-
Paris, Île-de-France, FranceRaDiCo-PP
Jul 26, 2023
Brain Structure and Clinical Endpoints in Myotonic Dystrophy
Recruiting
- Myotonic Dystrophy Type 2
- Non-interventional study
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
May 2, 2023
Myotonic Dystrophy 1 Trial in Oslo (Moderate-Heavy Resistance Exercise)
Recruiting
- Myotonic Dystrophy 1
- Moderate-Heavy Resistance Exercise
-
Oslo, NorwayNorwegian School of Sport Sciences
Aug 30, 2021